Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $11.1 million.

  • Lifecore Biomedical, Inc. \De\'s Operating Expenses fell 2671.43% to $11.1 million in Q2 2025 from the same period last year, while for May 2025 it was $53.1 million, marking a year-over-year increase of 478.56%. This contributed to the annual value of $50.6 million for FY2025, which is 27.02% down from last year.
  • As of Q2 2025, Lifecore Biomedical, Inc. \De\'s Operating Expenses stood at $11.1 million, which was down 2671.43% from $12.0 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s Operating Expenses' 5-year high stood at $21.3 million during Q1 2022, with a 5-year trough of $3.4 million in Q2 2022.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Operating Expenses value was $11.5 million (recorded in 2021), while the average stood at $12.1 million.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Operating Expenses plummeted by 7045.75% in 2022 and then surged by 32044.33% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Operating Expenses (Quarter) stood at $7.8 million in 2021, then surged by 42.01% to $11.0 million in 2022, then grew by 3.71% to $11.4 million in 2023, then rose by 14.01% to $13.0 million in 2024, then fell by 15.03% to $11.1 million in 2025.
  • Its Operating Expenses was $11.1 million in Q2 2025, compared to $12.0 million in Q1 2025 and $13.0 million in Q4 2024.